Physician profile
Anil Singh
NPI 1275847162
$12,753.96
in general payments reported to CMS, 2019-2025
36 companies · $2,487 in 2025
The $2,487 reported for 2025 was more than what 80% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2021: $930 · 2022: $1,738 · 2023: $5,543 · 2024: $1,902 · 2025: $2,487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,780 · Education: $3,075 · Travel and Lodging: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,779.70 |
| Education | $3,074.75 |
| Travel and Lodging | $1,077.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,258.45 | 2022-2023 | Ion, Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,758.64 | 2021-2025 | Trelegy Ellipta, Nucala, Jemperli |
| Astrazeneca Pharmaceuticals LP | $1,732.01 | 2021-2025 | Airsupra, Breztri, Fasenra |
| Actelion Pharmaceuticals US, INC. | $611.49 | 2021-2025 | Uptravi, Opsumit |
| Baxter Healthcare | $550.35 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Takeda Pharmaceuticals U.S.A., INC. | $455.58 | 2021-2025 | Glassia, Cuvitru |
| Genzyme Corporation | $450.67 | 2022-2025 | |
| Mylan Specialty L.P. | $326.08 | 2021-2024 | Yupelri |
| Amgen INC. | $279.34 | 2019-2025 | Tezspire |
| Viatris Specialty LLC | $243.00 | 2025 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $239.96 | 2024-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $233.84 | 2022-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.28 | 2021-2025 | Ofev |
| Janssen Pharmaceuticals, INC | $169.30 | 2021-2022 | |
| Grifols USA, LLC | $137.89 | 2021-2025 | Prolastin-C Liquid |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $134.22 | 2019 | |
| Merck Sharp & Dohme LLC | $111.54 | 2024-2025 | Winrevair |
| United Therapeutics Corporation | $103.08 | 2021-2024 | Tyvaso |
| Ani Pharmaceuticals, INC. | $101.75 | 2022-2024 | Purified Cortrophin Gel |
| Insmed, INC. | $91.43 | 2022-2025 | Arikayce |
| Gilead Sciences, INC. | $86.32 | 2021-2023 | Trodelvy |
| Bayer Healthcare Pharmaceuticals INC. | $80.74 | 2025 | |
| Verona Pharma, INC. | $75.69 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $55.76 | 2021-2022 | |
| Advanced Respiratory, INC | $36.77 | 2021 | |
| Janssen Biotech, INC. | $36.33 | 2022 | |
| Abbvie INC. | $27.76 | 2023 | Avycaz |
| Vifor Pharma, INC. | $25.71 | 2025 | Zemaira |
| Philips North America LLC | $24.11 | 2025 | Vest Therapy Und |
| Vapotherm INC | $23.24 | 2022 | |
| Boston Scientific Corporation | $19.68 | 2023 | Acquire |
| Ethicon INC. | $19.12 | 2025 | Monarch Platform |
| Harmony Biosciences LLC | $18.33 | 2023 | Wakix |
| Genentech USA, INC. | $15.79 | 2022 | |
| Atricure, INC. | $13.61 | 2024 | |
| Itamar Medical INC | $12.10 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.